Press release from Companies
Publicerat: 2019-04-30 08:54:48
Respiratorius presents Annual Report 2018
Lund April 30, 2019d The Board Johan Drott President Respiratorius AB +46 709-22 41 40 johan.drott@respiratorius.com Respiratorius AB (publ) is developing drug candidates with the goal to launch drugs for common diseases cancer, chronic obstructive pulmonary disease (COPD) and severe asthma. In addition, the project portfolio is a project for improved diagnosis of certain cardiovascular diseases.